Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci185422 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Jan Pieter R Koopman und 18 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Center for Infectious Diseases. Hauptthemen laut MEDLINE: Praziquantel, Schistosoma mansoni, Schistosomiasis mansoni, Anthelmintics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.
Abstract (Originalsprache)
BACKGROUND Partial protective immunity to schistosomiasis develops over time, following repeated praziquantel (PZQ) treatment. Moreover, animals develop protective immunity after repeated immunization with irradiated cercariae. Here, we evaluated the development of natural immunity through consecutive exposure-treatment cycles with Schistosoma mansoni in healthy, Schistosoma -naive participants using single-sex, controlled human S. mansoni infection. METHODS Twenty-four participants were randomized in a double-blinded (1:1) manner to either the reinfection group, which received 3 exposures (weeks 0, 9, and 18) to 20 male cercariae, or to the infection control group, which received 2 mock exposures with water (weeks 0 and 9) prior to cercariae exposure (week 18). Participants were treated with PZQ (or placebo) at weeks 8, 17, and 30. Attack rates (ARs) after the final exposure (weeks 19–30) using serum circulating anodic antigen (CAA) positivity were compared between groups. Adverse events (AEs) were collected for safety. RESULTS Twenty-three participants completed the follow-up. No protective efficacy was observed, given an 82% (9 of 11) AR after the final exposure in the reinfection group and 92% (11 of 12) in the infection control group (protective efficacy 11%; 95% CI –24% to 35%; P = 0.5). Related AEs were higher after the first infection (45%) compared with the second (27%) and third (28%) infections. Severe acute schistosomiasis was observed after the first infections only (2 of 12 in the reinfection group and 2 of 12 in the infection control group). CONCLUSION Repeated Schistosoma exposure and treatment cycles resulted in apparent clinical tolerance, with fewer symptoms reported following subsequent infections, but did not result in protection against reinfection. TRIAL REGISTRATION ClinicalTrials.gov NCT05085470. FUNDING European Research Council (ERC) Starting Grant (no. 101075876).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leiden University Center for Infectious Diseases.
- Department of Cell and Chemical Biology.
- Department of Clinical Pharmacy and Toxicology, and.
- Center for Cell and Gene therapy, Leiden University Medical Center (LUMC), Leiden, Netherlands.
Förderung
- European Research Council
Zitieren
APA
Koopman, J. P. R., Houlder, E. L., Janse, J. J., Lamers, O. A., Roozen, G. V., Sijtsma, J. C., Casacuberta-Partal, M., Hilt, S. T., van der Stoep, M. Y. E. C., van Amerongen-Westra, I. M., Brienen, E. A., Wammes, L. J., van Lieshout, L., van Dam, G. J., Corstjens, P. L., van Diepen, A., Yazdanbakhsh, M., Hokke, C. H., & Roestenberg, M. (2025). Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection. Journal of Clinical Investigation. https://doi.org/10.1172/jci185422
Vancouver
Koopman JPR, Houlder EL, Janse JJ, Lamers OA, Roozen GV, Sijtsma JC, et al. Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection. Journal of Clinical Investigation. 2025. doi:10.1172/jci185422
BibTeX
@article{Koopman2025,
author = {Koopman, Jan Pieter R and Houlder, Emma L and Janse, Jacqueline J and Lamers, Olivia Ac and Roozen, Geert Vt and Sijtsma, Jeroen C and Casacuberta-Partal, Miriam and Hilt, Stan T and van der Stoep, M Y Eileen C and van Amerongen-Westra, Inge M and Brienen, Eric At and Wammes, Linda J and van Lieshout, Lisette and van Dam, Govert J and Corstjens, Paul Lam and van Diepen, Angela and Yazdanbakhsh, Maria and Hokke, Cornelis H and Roestenberg, Meta},
title = {Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci185422}
}
EUVIMED